IPK in the News

[Korea Economy] Bio-venture company Qurient to go public on KOSDAQ this week

2016-02-26

 

The Ministry of Science, ICT and Future Planning(MSIP) announced Qurient, Co. Ltd. a spin-off of Institut Pasteur Korea (IPK), will go public on KOSDAQ on Feb. 29, 2016. Qurient was founded by IPK to usher drug candidates to pre-clinical and clinical trials and as a vehicle to transfer technology to pharmaceuticals in Korea. 


Source: Korea Economy (24 February, 2016)